Literature DB >> 31151112

Challenging Knosp high-grade pituitary adenomas.

Alexander Micko1, Johannes Oberndorfer1, Wolfgang J Weninger2, Greisa Vila3, Romana Höftberger4, Stefan Wolfsberger1, Engelbert Knosp1.   

Abstract

OBJECTIVE: Parasellar growth is one of the most important prognostic variables of pituitary adenoma surgery, with adenomas regarded as not completely resectable if they invade the cavernous sinus (CS) but potentially curable if they displace CS structures. This study was conducted to correlate surgical treatment options and outcomes to the different biological behaviors (invasion vs displacement) of adenomas with parasellar extension into the superior or inferior CS compartments or completely encasing the carotid artery (Knosp high grades 3A, 3B, and 4).
METHODS: This was a retrospective cohort analysis of 106 consecutive patients with Knosp high-grade pituitary adenomas with parasellar extension who underwent surgery via a primary endoscopic transsphenoidal approach between 2003 and 2017. Biological tumor characteristics (surgical status of invasiveness and tumor texture, 2017 WHO classification, proliferation rate), extent of resection, and complication rate were correlated with parasellar extension grades 3A, 3B, and 4 on preoperative MRI studies.
RESULTS: Invasiveness was significantly less common in grade 3A (44%) than in grade 3B (72%, p = 0.037) and grade 4 (100%, p < 0.001) adenomas. Fibrous tumor texture was significantly more common in grade 4 (52%) compared to grade 3A (20%, p = 0.002), but not compared to grade 3B (28%) adenomas. Functioning macroadenomas had a significantly higher rate of invasiveness than nonfunctioning adenomas (91% vs 55%, p = 0.002). Mean proliferation rate assessed by MIB-1 was > 3% in all groups but without significant difference between the groups (grade 3A, 3.2%; 3B, 3.9%; 4, 3.7%). Rates of endocrine remission/gross-total resection were significantly higher in grade 3A (64%) than in grade 3B (33%, p = 0.021) and grade 4 (0%, p < 0.001) adenomas. In terms of complication rates, no significant difference was observed between grades.
CONCLUSIONS: According to the authors' data, the biological behavior of pituitary adenomas varies significantly between parasellar extension patterns. Adenomas with extension into the superior CS compartment have a lower rate of invasive growth than adenomas extending into the inferior CS compartment or encasing the carotid artery. Consequently, a significantly higher rate of remission can be achieved in grade 3A than in grade 3B and grade 4 adenomas. Therefore, the distinction into grades 3A, 3B, and 4 is of importance for prediction of adenoma invasion and surgical treatment considerations.

Entities:  

Keywords:  Knosp grading; cavernous sinus; invasion; pituitary adenoma; pituitary surgery

Year:  2019        PMID: 31151112     DOI: 10.3171/2019.3.JNS19367

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

1.  Classifying Pituitary Adenoma Invasiveness Based on Radiological, Surgical and Histological Features: A Retrospective Assessment of 903 Cases.

Authors:  Liang Lu; Xueyan Wan; Yu Xu; Juan Chen; Kai Shu; Ting Lei
Journal:  J Clin Med       Date:  2022-04-27       Impact factor: 4.964

2.  ST8SIA6-AS1 Promotes the Epithelial-to-Mesenchymal Transition and Angiogenesis of Pituitary Adenoma.

Authors:  Zuowei Li; Chengcheng Zhang; Xin Zong; Zhao Wang; Rong Ren; Lei Wang; Ping Sun; Chunmei Zhu; Mingxia Guo; Guizhen Guo; Guo Hu; Ya'nan Wu
Journal:  J Oncol       Date:  2022-06-22       Impact factor: 4.501

3.  A Convolutional Neural Network Model for Detecting Sellar Floor Destruction of Pituitary Adenoma on Magnetic Resonance Imaging Scans.

Authors:  Tianshun Feng; Yi Fang; Zhijie Pei; Ziqi Li; Hongjie Chen; Pengwei Hou; Liangfeng Wei; Renzhi Wang; Shousen Wang
Journal:  Front Neurosci       Date:  2022-07-04       Impact factor: 5.152

Review 4.  Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions.

Authors:  Liang Lu; Xueyan Wan; Yu Xu; Juan Chen; Kai Shu; Ting Lei
Journal:  Diagnostics (Basel)       Date:  2022-04-13

5.  Application of Convolutional Neural Network in the Diagnosis of Cavernous Sinus Invasion in Pituitary Adenoma.

Authors:  Yi Fang; He Wang; Ming Feng; Hongjie Chen; Wentai Zhang; Liangfeng Wei; Zhijie Pei; Renzhi Wang; Shousen Wang
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

6.  Line Scan Raman Microspectroscopy for Label-Free Diagnosis of Human Pituitary Biopsies.

Authors:  Daniela Bovenkamp; Alexander Micko; Jeremias Püls; Fabian Placzek; Romana Höftberger; Greisa Vila; Rainer Leitgeb; Wolfgang Drexler; Marco Andreana; Stefan Wolfsberger; Angelika Unterhuber
Journal:  Molecules       Date:  2019-10-04       Impact factor: 4.411

7.  Predicting the Need for Desmopressin Treatment During Inpatient and After Discharge Following Endoscopic Sellar Surgery.

Authors:  Chia-En Wong; Wei-Hsin Wang; Ming-Ying Lan; Po-Hsuan Lee; Chi-Chen Huang; Pei-Fang Su; Jung-Shun Lee
Journal:  Front Neurol       Date:  2022-02-17       Impact factor: 4.003

8.  Radiological Knosp, Revised-Knosp, and Hardy-Wilson Classifications for the Prediction of Surgical Outcomes in the Endoscopic Endonasal Surgery of Pituitary Adenomas: Study of 228 Cases.

Authors:  Marta Araujo-Castro; Alberto Acitores Cancela; Carlos Vior; Eider Pascual-Corrales; Víctor Rodríguez Berrocal
Journal:  Front Oncol       Date:  2022-01-20       Impact factor: 6.244

9.  Invasive Corridor of Clivus Extension in Pituitary Adenoma: Bony Anatomic Consideration, Surgical Outcome and Technical Nuances.

Authors:  Xiao Wu; Han Ding; Le Yang; Xuan Chu; Shenhao Xie; Youyuan Bao; Jie Wu; Youqing Yang; Lin Zhou; Minde Li; Shao Yang Li; Bin Tang; Limin Xiao; Chunlong Zhong; Liang Liang; Tao Hong
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

10.  Optimizing MR imaging for intraoperative image guidance in sellar pathologies.

Authors:  Alexander Micko; Arthur Hosmann; Wolfgang Marik; Sophie Bartsch; Michael Weber; Engelbert Knosp; Stefan Wolfsberger
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.